Delivery Order SPE2DB25D7068-SPE2DB25FTVCS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count packages) valued at $3,508.43. This contract utilizes a firm fixed-price structure with an ultimate completion date of September 26, 2025, and was awarded on a competitive basis without any set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) valued at $3,328.77. This firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a non-competitive delivery against AmerisourceBergen's larger indefinite delivery contract with DLA. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at approximately $61.2K to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180-count units). This contract, which was competitively awarded with no set-aside designation, became effective on July 24, 2025, with an ultimate completion date of July 25, 2025. The firm fixed-price delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) with a ceiling value of $19,423.78. This firm fixed-price delivery order represents a non-set-aside, competitively awarded transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX. The ultimate completion date for this delivery order is August 5,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180-count units) under a firm fixed-price contract valued at $42,806.16. The delivery order, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive award. AmerisourceBergen will perform this pharmaceutical supply obligation from its corporate office location in Conshohocken, Pennsylvania, serving the...
- The Defense Logistics Agency awarded a delivery order valued at $67,347.84 to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180-count units) on September 13, 2025, with a completion date of September 15, 2025. The award carries no set-aside designation and utilizes firm fixed pricing under a delivery order contract type. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180-count) in the amount of $1,908.41. The contract was awarded on June 16, 2025, with an ultimate completion date of June 17, 2025. This non-competitive delivery order represents a firm fixed-price transaction under AmerisourceBergen's existing Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order valued at $4,370.27 to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180-count units). This firm fixed-price delivery order, awarded on September 2, 2025, with completion targeted for September 3, 2025, represents a routine pharmaceutical procurement executed through open competition with no set-aside designation. The vendor, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,086.48 to supply Janumet XR 100-1,000 mg tablets (90-count) with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order under a larger contract vehicle. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) with a ceiling value of $3,514.89. This is a firm fixed-price delivery order with no set-aside designation, executed under a competitive procurement process. The delivery order is scheduled for completion by September 29, 2025, and will be fulfilled from the contractor's corporate office location in Conshohocken,...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTVCSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,238.40 to AmerisourceBergen Drug Corp for Janumet XR 50-1,000 mg tablets (180 count) on January 22, 2025, with completion scheduled for January 23, 2025. This firm fixed price delivery order, which carries no set-aside designation, was competitively awarded and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply chain operations. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceuticals and medical supplies to military healthcare programs globally, supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The current delivery order for Janumet XR, a combination medication used in diabetes management, reflects the company's established role as a critical pharmaceutical distributor within the federal medical procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/22/25 |